Guidelines for prescribing generic medicines in public hospitals
The Press Information Bureau has released a press release on 13th December, 2022 on the guidelines for prescribing generic medicines in public hospitals. The Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 formed under Indian Medical Council Act, 1956 (102 of 1956), provides for conduct for doctors and professional association of doctors in their relationship with pharmaceutical and allied health sector industry. Under this, any complaint of professional misconduct of a medical practitioner or professional is to be addressed by the respective State Medical Councils.
Pharmaceutical Technology Upgradation Assistance Scheme for MSMEs
The Press Information Bureau has released a press release on 13th December, 2022 on pharma technology upgradation assistance scheme. Micro, Small and Medium Enterprises (MSMEs) have availed the benefit under erstwhile Pharmaceutical Technology Upgradation Assistance (PTUAS) scheme. However, since July 2022, PTUAS has been incorporated as a sub-scheme under the Strengthening of Pharmaceutical Industry (SPI) Scheme.
Uniform Code of Pharmaceutical Marketing Practices (UCPMP)
The Government has put in place a voluntary Uniform Code for Pharmaceutical Marketing Practices (UCPMP) for Pharmaceutical companies, which is in operation since 01.01.2015. The code details its mode of operation, responsibilities of the Pharmaceutical Associations in constituting the Ethics Committee for Pharmaceutical Marketing Practices (ECPMP) for handling the complaints and Apex Ethics Committee for Pharmaceutical Marketing Practices (AECPMP) for review, procedure of lodging a complaint, procedure of handling of complaints by the Pharmaceutical Associations and various penalty provisions.
Assurance of Quality Control of Ayush Drugs
The Press Information Bureau has released a press release on 13th December, 2022 on the assurance of quality control of ayush drugs. In this context, the ministry of Ayush has taken various steps for assured quality control of AYUSH drugs in the country. The ministry has formulated various schemes to support ayurvedic medicines production. Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) lays down Pharmacopeial Standards and Formulary specifications for Ayurveda, Siddha, Unani and Homoeopathy (ASU&H) drugs. Further, PCIM&H also receives the samples from Government agencies for ascertaining their quality.
NPPA publishes its Draft Version Of Calculation Of Ceiling Price For 69 Formulations
These lists were added into the Schedule-1 of the Drugs (Price Control) Order (DPCO), 2013. The computation of ceiling price is based on July 2022 data under para 4 of DPCO, 2013. The ceiling price revision was announced recently after the revision of Schedule 1 of the Drugs (Price Control) Order, 2013 replacing NLEM 2015 with NLEM 2022,
Insurance Regulatory and Development Authority of India (Appointed Actuary) Regulations, 2022
The regulations provides the process of appointment of an actuary and necessary qualifications.
Insurance Regulatory and Development Authority of India (Actuarial Report and Abstract for Life Insurance Business) (Amendment) Regulations, 2022
The amendment revises the Required Solvency Margin (RSM) factors forming part of Form KT-1.
Insurance Regulatory and Development Authority of India (Assets, Liabilities and Solvency Margin of General Insurance Business) (Amendment) Regulations, 2022
The amendment revises the Required Solvency Margin based on Net Premium and Net Incurred Claims‟ of Form IRDAIGI- SM.
UGC Curriculum and Credit Framework for Undergraduate Programmes (CCFUP)
In accordance with the NEP 2020, the UGC has formulated a new student-centric “Curriculum and Credit Framework for Undergraduate Programmes (CCFUP)” incorporating a flexible choice-based credit system, multidisciplinary approach, and multiple entry and exit options.
BSE Guidance note on the inclusion of “Object of the issue” in case of Preferential issues and Qualified Institutions Placement
The Exchange will be verifying compliance with the aforesaid disclosure requirements at the time of processing the application filed by the issuers under Regulation 28(1) of the SEBI (LODR) Regulations, 2018 seeking in-principle approval of the Exchange before making allotment of securities.
